Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Sorafenib Pharmacokinetics
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine
SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma - ScienceDirect
Potential mechanisms of action of Sorafenib in RCC. Note: Sorafenib can... | Download Scientific Diagram
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer - ScienceDirect
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC
Frontiers | Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models | Oncology
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma | Cell Communication and Signaling | Full Text
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
Frontiers | Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma | Pharmacology
Cancers | Free Full-Text | Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity | HTML
Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again… - Journal of Hepatology
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
View of SUSTAINED RELEASE TABLETS OF SORAFENIB-SILIBININ COMBINATIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | International Journal of Applied Pharmaceutics
Supplemental Materials for Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology
Sorafenib Pharmacodynamics
Sorafenib - Mechanism of Action in treating Advanced Hepatocellular Carcinoma by asukaccp - Issuu
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
